HAE
Haemonetics Corporation
NYSE: HAE · HEALTHCARE · MEDICAL DEVICES
$52.67
-5.30% today
Updated 2026-05-06
Market cap
$2.75B
P/E ratio
16.33
P/S ratio
2.09x
EPS (TTM)
$3.63
Dividend yield
—
52W range
$47 – $87
Volume
0.7M
Haemonetics Corporation (HAE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
13.30%
Operating margin
21.00%
ROE
19.30%
ROA
6.45%
Debt/equity
1.34x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $419.73M | $69.08M | 52.54% | 23.59% | 16.46% |
| 2007 | $449.61M | $49.11M | 50.56% | 13.96% | 10.92% |
| 2008 | $516.44M | $51.98M | 49.90% | 13.61% | 10.07% |
| 2009 | $597.88M | $59.30M | 51.54% | 14.31% | 9.92% |
| 2010 | $645.43M | $58.38M | 52.29% | 12.90% | 9.04% |
| 2011 | $676.69M | $79.98M | 52.49% | 16.34% | 11.82% |
| 2012 | $727.84M | $66.89M | 50.73% | 12.19% | 9.19% |
| 2013 | $891.99M | $38.80M | 48.00% | 6.33% | 4.35% |
| 2014 | $938.51M | $35.15M | 49.91% | 5.04% | 3.75% |
| 2015 | $910.37M | $16.90M | 47.72% | 4.45% | 1.86% |
| 2016 | $908.83M | $-55.62M | 44.66% | -4.83% | -6.12% |
| 2017 | $886.12M | $-26.27M | 42.71% | -2.19% | -2.96% |
| 2018 | $903.92M | $45.57M | 45.57% | 6.21% | 5.04% |
| 2019 | $967.58M | $55.02M | 43.15% | 8.63% | 5.69% |
| 2020 | $988.48M | $76.53M | 49.35% | 10.46% | 7.74% |
| 2021 | $870.46M | $79.47M | 49.22% | 10.31% | 9.13% |
| 2022 | $993.20M | $43.38M | 53.44% | 8.13% | 4.37% |
| 2023 | $1.17B | $115.40M | 53.30% | 13.35% | 9.87% |
| 2024 | $1.31B | $117.56M | 54.38% | 12.60% | 8.98% |
| 2025 | $1.36B | $167.68M | 57.21% | 16.30% | 12.32% |